Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy

References

• Antwi SO , Mousa OY , Patel T . Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995–2014. Ann Hepatol . 2018;17(4):604–614. doi:10.5604/01.3001.0012.0929 29893702
   PubMed Web of Science ®Google Scholar
• Khan SA , Tavolari S , Brandi G . Cholangiocarcinoma: epidemiology and risk factors. Liver Int . 2019;39(Suppl S1):19–31. doi:10.1111/liv.14095 30851228
   PubMed Web of Science ®Google Scholar
• Bertuccio P , Malvezzi M , Carioli G , et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol . 2019;71(1):104–114. doi:10.1016/j.jhep.2019.03.013 30910538
   PubMed Web of Science ®Google Scholar
• Razumilava N , Gores GJ . Cholangiocarcinoma. Lancet . 2014;383(9935):2168–2179. doi:10.1016/S0140-6736(13)61903-0 24581682
   PubMed Web of Science ®Google Scholar
• Mavros MN , Economopoulos KP , Alexiou VG , Pawlik TM . Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic Review and meta-analysis. JAMA Surg . 2014;149(6):565–574. doi:10.1001/jamasurg.2013.5137 24718873
   PubMed Web of Science ®Google Scholar
• Endo I , Gonen M , Yopp AC , et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg . 2008;248(1):84–96. doi:10.1097/SLA.0b013e318176c4d3 18580211
   PubMed Web of Science ®Google Scholar
• Allen RA , Lisa JR . Combined liver cell and bile duct carcinoma. Am J Pathol . 1949;25(4):647–655.18152860
   PubMed Web of Science ®Google Scholar
• Jarnagin WR , Weber S , Tickoo SK , et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer . 2002;94(7):2040–2046. doi:10.1002/cncr.10392 11932907
   PubMed Web of Science ®Google Scholar
• Yeh MM . Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol . 2010;25(9):1485–1492. doi:10.1111/j.1440-1746.2010.06430.x 20796144
   PubMed Web of Science ®Google Scholar
• Zuo H-Q , Yan L-N , Zeng Y , et al. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int . 2007;6(2):161–165.17374575
   PubMed Web of Science ®Google Scholar
• Lee J-H , Chung GE , Yu SJ , et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol . 2011;45(1):69–75. doi:10.1097/MCG.0b013e3181ce5dfa 20142755
   PubMed Web of Science ®Google Scholar
• Piha-Paul SA , Oh D-Y , Ueno M , et al. Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: results from the KEYNOTE-158 and KEYNOTE-028 studies. Int J Cancer . 2020;147(8):2190–2198. doi:10.1002/ijc.33013 32359091
   PubMed Web of Science ®Google Scholar
• Ueno M , Ikeda M , Morizane C , et al. Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, Phase 1 study. Lancet Gastroenterol Hepatol . 2019;4(8):611–621. doi:10.1016/S2468-1253(19)30086-X 31109808
   PubMed Web of Science ®Google Scholar
• Jiricny J . Postreplicative mismatch repair. Cold Spring Harb Perspect Biol . 2013;5(4):a012633. doi:10.1101/cshperspect.a012633 23545421
   PubMed Web of Science ®Google Scholar
• Shia J . Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma. Semin Diagn Pathol . 2015;32(5):352–361. doi:10.1053/j.semdp.2015.02.018 25716099
   PubMed Web of Science ®Google Scholar
• Boland CR , Goel A . Microsatellite instability in colorectal cancer. Gastroenterology . 2010;138(6):2073–2087.e3. doi:10.1053/j.gastro.2009.12.064 20420947
   PubMed Web of Science ®Google Scholar
• Karamurzin Y , Zeng Z , Stadler ZK , et al. Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol . 2012;43(10):1677–1687. doi:10.1016/j.humpath.2011.12.012 22516243
   PubMed Web of Science ®Google Scholar
• Vasen HF . What is hereditary nonpolyposis colorectal cancer (HNPCC). Anticancer Res . 1994;14(4B):1613–1615.7979195
   PubMed Web of Science ®Google Scholar
• Watson P , Vasen HFA , Mecklin J-P , et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer . 2008;123(2):444–449. doi:10.1002/ijc.23508 18398828
   PubMed Web of Science ®Google Scholar
• Le DT , Durham JN , Smith KN , et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science . 2017;357(6349):409–413. doi:10.1126/science.aan6733 28596308
   PubMed Web of Science ®Google Scholar
• Le DT , Uram JN , Wang H , et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med . 2015;372(26):2509–2520. doi:10.1056/NEJMoa1500596 26028255
   PubMed Web of Science ®Google Scholar
• Overman MJ , McDermott R , Leach JL , et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, Phase 2 study. Lancet Oncol . 2017;18(9):1182–1191. doi:10.1016/S1470-2045(17)30422-9 28734759
   PubMed Web of Science ®Google Scholar
• Marcus L , Lemery SJ , Keegan P , Pazdur R . FDA approval summary: pembrolizumab for the treatment of microsatellite instability-high solid tumors. Clin Cancer Res . 2019;25(13):3753–3758. doi:10.1158/1078-0432.CCR-18-4070 30787022
   PubMed Web of Science ®Google Scholar
• Hause RJ , Pritchard CC , Shendure J , Salipante SJ . Classification and characterization of microsatellite instability across 18 cancer types. Nat Med . 2016;22(11):1342–1350. doi:10.1038/nm.4191 27694933
   PubMed Web of Science ®Google Scholar
• Cloyd JM , Chun YS , Ikoma N , et al. Clinical and genetic implications of DNA mismatch repair deficiency in biliary tract cancers associated with lynch syndrome. J Gastrointest Cancer . 2018;49(1):93–96. doi:10.1007/s12029-017-0040-9 29238914
   PubMed Web of Science ®Google Scholar
• Sessa F , Furlan D , Genasetti A , Billo P , Feltri M , Capella C . Microsatellite instability and p53 expression in gallbladder carcinomas. Diagn Mol Pathol . 2003;12(2):96–102. doi:10.1097/00019606-200306000-00005 12766614
   PubMedGoogle Scholar
• Saetta AA , Papanastasiou P , Michalopoulos NV , et al. Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. Virchows Arch . 2004;445(2):179–182. doi:10.1007/s00428-004-1046-9 15221372
   PubMed Web of Science ®Google Scholar
• Winkelmann R , Schneider M , Hartmann S , et al. Microsatellite instability occurs rarely in patients with cholangiocarcinoma: a retrospective Study from a German Tertiary Care Hospital. Int J Mol Sci . 2018;19(5):1421. doi:10.3390/ijms19051421
   PubMed Web of Science ®Google Scholar
• Goeppert B , Roessler S , Renner M , et al. Mr fluke associated cholangiismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liveocarcinoma. Br J Cancer . 2019;120(1):109–114.30377340
   PubMed Web of Science ®Google Scholar
• Momoi H , Itoh T , Nozaki Y , et al. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma. J Hepatol . 2001;35(2):235–244. doi:10.1016/S0168-8278(01)00106-4 11580146
   PubMed Web of Science ®Google Scholar
• Suto T , Habano W , Sugai T , et al. Infrequent microsatellite instability in biliary tract cancer. J Surg Oncol . 2001;76(2):121–126. doi:10.1002/1096-9098(200102)76:2<121::AID-JSO1022>3.0.CO;2-7 11223838
   PubMed Web of Science ®Google Scholar
• Ju JY , Dibbern ME , Mahadevan MS , Fan J , Kunk PR , Stelow EB . Mismatch repair protein deficiency/microsatellite instability is rare in cholangiocarcinomas and associated with distinctive morphologies. Am J Clin Pathol . 2020;153(5):598–604. doi:10.1093/ajcp/aqz199 31844887
   PubMed Web of Science ®Google Scholar
• Vanderwalde A , Spetzler D , Xiao N , Gatalica Z , Marshall J . Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients. Cancer Med . 2018;7(3):746–756. doi:10.1002/cam4.1372 29436178
   PubMed Web of Science ®Google Scholar
• Spizzo G , Puccini A , Xiu J , et al. Molecular profile of BRCA-mutated biliary tract cancers. ESMO Open . 2020;5(3):e000682. doi:10.1136/esmoopen-2020-000682 32576609
   PubMed Web of Science ®Google Scholar
• Czink E , Kloor M , Goeppert B , et al. Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer. Cold Spring Harb Mol Case Stud . 2017;3(5):a001974. doi:10.1101/mcs.a001974 28619747
   PubMed Web of Science ®Google Scholar
• Schwitalle Y , Kloor M , Eiermann S , et al. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology . 2008;134(4):988–997. doi:10.1053/j.gastro.2008.01.015 18395080
   PubMed Web of Science ®Google Scholar
• Kloor M , von Knebel Doeberitz M . The immune biology of microsatellite-unstable cancer. Trends Cancer . 2016;2(3):121–133. doi:10.1016/j.trecan.2016.02.004 28741532
   PubMed Web of Science ®Google Scholar
• Goeppert B , Roessler S , Renner M , et al. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. Br J Cancer . 2019;120(1):109–114. doi:10.1038/s41416-018-0199-2 30377340
   PubMed Web of Science ®Google Scholar
• Silva VW , Askan G , Daniel TD , et al. Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency. Chin Clin Oncol . 2016;5(5):62. doi:10.21037/cco.2016.10.04 27829276
   PubMed Web of Science ®Google Scholar
• Goldstein J , Tran B , Ensor J , et al. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol . 2014;25(5):1032–1038. doi:10.1093/annonc/mdu100 24585723
   PubMed Web of Science ®Google Scholar
• Popat S , Hubner R , Houlston RS . Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol . 2005;23(3):609–618. doi:10.1200/JCO.2005.01.086 15659508
   PubMed Web of Science ®Google Scholar
• Kato M , Takano M , Miyamoto M , et al. DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers. J Gynecol Oncol . 2015;26(1):40–45. doi:10.3802/jgo.2015.26.1.40 25310854
   PubMed Web of Science ®Google Scholar